Common Stock, Shares, Issued of Adverum Biotechnologies, Inc. from 31 Dec 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Adverum Biotechnologies, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2013 to 31 Dec 2024.
  • Adverum Biotechnologies, Inc. Common Stock, Shares, Issued for the quarter ending 31 Dec 2024 was 20,848,000, a 106% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Adverum Biotechnologies, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 20,848,000 +10,705,000 +106% 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q4 2023 10,143,000 -89,974,000 -90% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q4 2022 100,117,000 +1,736,000 +1.8% 31 Dec 2022 10-K 18 Mar 2024 2023 FY
Q4 2021 98,381,000 +832,000 +0.85% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q4 2020 97,549,000 +30,220,000 +45% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q4 2019 67,329,000 +4,364,000 +6.9% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q4 2018 62,965,000 +13,949,661 +28% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 62,826,416 +19,309,004 +44% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 62,637,111 +19,435,325 +45% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 62,232,372 +19,452,117 +45% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 49,015,339 +7,210,330 +17% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q3 2017 43,517,412 +1,798,897 +4.3% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 43,201,786 +1,879,429 +4.5% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 42,780,255 +15,685,300 +58% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 41,805,009 +15,946,287 +62% 31 Dec 2016 10-K 06 Mar 2018 2017 FY
Q3 2016 41,718,515 +15,962,458 +62% 30 Sep 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 41,322,357 +15,647,368 +61% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 27,094,955 +1,621,017 +6.4% 31 Mar 2016 10-Q 06 May 2016 2016 Q1
Q4 2015 25,858,722 +3,104,685 +14% 31 Dec 2015 10-K 09 Mar 2017 2016 FY
Q3 2015 25,756,057 +3,285,758 +15% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 25,674,989 +22,002,104 +599% 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 25,473,938 31 Mar 2015 10-Q 13 May 2015 2015 Q1
Q4 2014 22,754,037 +19,081,152 +520% 31 Dec 2014 10-K 04 Mar 2016 2015 FY
Q3 2014 22,470,299 30 Sep 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 3,672,885 30 Jun 2014 10-Q 12 Sep 2014 2014 Q2
Q4 2013 3,672,885 31 Dec 2013 10-K 05 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.